Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Xian Yang Li"'
Autor:
Xiaobing Duan, Jiali Hu, Yuncong Zhang, Xiaoguang Zhao, Mingqi Yang, Taoping Sun, Siya Liu, Xin Chen, Juan Feng, Wenting Li, Ze Yang, Yitian Zhang, Xiaowen Lin, Dingjie Liu, Ya Meng, Guang Yang, Qiuping Lin, Guihai Zhang, Haihong Lei, Zhengsheng Yi, Yanyan Liu, Xiaobing Liang, Yujuan Wu, Wenqing Diao, Zesong Li, Haihai Liang, Meixiao Zhan, Hong-Wei Sun, Xian-Yang Li, Ligong Lu
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 11, Pp 3005-3025 (2024)
Abstract Retinoic acid-inducible gene I (RIG-I) is a pattern recognition receptor involved in innate immunity, but its role in adaptive immunity, specifically in the context of CD8+ T-cell antitumour immunity, remains unclear. Here, we demonstrate th
Externí odkaz:
https://doaj.org/article/59d8b008363244d1ad0a57728bdc6b90
Autor:
Yao Liu, Zhongliang Li, Xiaoguang Zhao, Jing Xiao, Jiacheng Bi, Xian-Yang Li, Guokai Chen, Ligong Lu
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract The ATP-adenosine pathway has emerged as a promising target for cancer therapy, but challenges remain in achieving effective tumor control. Early research focused on blocking the adenosine generating enzyme CD73 and the adenosine receptors A
Externí odkaz:
https://doaj.org/article/8c568c00c55e4cf8b7b3d656ba2af344
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/4fd5d924a5cc4a3da1f6887bf7b7a6b5
Autor:
Chao Cheng, Jiantao Wang, Xiaowen He, Zhenwei Zhong, Ermin Xie, Xinyi Huang, Suo Chu, Xiaorui Chen, Bixia Lei, Huajing Wang Xian-Yang Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b1603af9e478453ca816ac7d6c03edc3
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e9fb3b9d12084878a3e6e2fdc89a4b28
Autor:
Yuting Zhang, Jincai Zhou, Zhongjun Shi, Feifei Shi, Siye Chen, Chenyu Huang, Huijiao Li, Ruirong Yi, Huajing Wang, Xian-Yang Li, Xiaowen He
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ced11fc7956f4911ba1d5d4c5496c200
Autor:
Yu-Chen Zhang, Xian-Yang Li, Qi Deng, Yan-Jun Ge, Rui-Rong Yi, Hua-Jing Wang, Jian-Tao Wang, Hui Zhou, Xue-Feng Kong, Rong-Jiao Liu, Yu-Ting Zhang, Xiao-Pei Li, Xiao-Wen He, Hai-Yan Zhu
Publikováno v:
Theranostics; 2024, Vol. 14 Issue 16, p6249-6267, 19p
Autor:
Ligong Lu, Meixiao Zhan, Xian-Yang Li, Hui Zhang, Danielle J. Dauphars, Jun Jiang, Hua Yin, Shi-You Li, Sheng Luo, Yong Li, You-Wen He
Publikováno v:
Current Research in Immunology, Vol 3, Iss , Pp 118-127 (2022)
Immune-checkpoint inhibitor-based combination immunotherapy has become a first-line treatment for several major types of cancer including hepatocellular carcinoma (HCC), renal cell carcinoma, lung cancer, cervical cancer, and gastric cancer. Combinat
Externí odkaz:
https://doaj.org/article/d4659b11267649d0a3c5cf3b7e2265ff
Autor:
Wenting Li, Xiaobing Duan, Xingxing Chen, Meixiao Zhan, Haichuan Peng, Ya Meng, Xiaobin Li, Xian-Yang Li, Guofu Pang, Xiaohui Dou
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Epstein–Barr virus (EBV) was the first tumor virus in humans. Nasopharyngeal carcinoma (NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV infection worldwide each year. NPC has an insidious onset and is highly maligna
Externí odkaz:
https://doaj.org/article/a1b17ab6f1bf46358c08e83b220365a3
Autor:
Xian-Yang Li, Indrajit Das, Ailin Lepletier, Venkateswar Addala, Tobias Bald, Kimberley Stannard, Deborah Barkauskas, Jing Liu, Amelia Roman Aguilera, Kazuyoshi Takeda, Matthias Braun, Kyohei Nakamura, Sebastien Jacquelin, Steven W. Lane, Michele W.L. Teng, William C. Dougall, Mark J. Smyth
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/c9ff9423cab74ff68d9f525d5673d4ce